Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study
Cancer Chemotherapy and Pharmacology1992Vol. 30(4), pp. 307–316
Citations Over TimeTop 21% of 1992 papers
Carlo Maurizio Camaggi, Elena Strocchi, Patrizia Carisi, Andrea Martoni, A Tononi, M. Guaraldi, Margherita Strolin‐Benedetti, Constantin Efthymiopoulos, F Pannuti
Related Papers
- → A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia(1998)161 cited
- → Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia(2021)9 cited
- → Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia(2009)6 cited
- → Therapeutic Activity of 4-Demethoxydauno-Rubicin (Idarubicin) in Adult Acute Leukemia(1983)19 cited
- → Idarubicin(2007)